Back to top
more

DexCom (DXCM)

(Real Time Quote from BATS)

$75.93 USD

75.93
1,848,936

-0.62 (-0.81%)

Updated Sep 17, 2025 12:06 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (93 out of 245)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Will Core Renal Care Unit Fuel Baxter's (BAX) Q4 Earnings?

by Zacks Equity Research

Management at Baxter (BAX) expects Renal Care to see growth of 3-4% in 2018.

Zacks Equity Research

Varian (VAR) Meets Q1 Earnings Estimates, Grows Globally

by Zacks Equity Research

Solid overseas growth boosts Varian's (VAR) fiscal Q1 results.

Zacks Equity Research

PetMed (PETS) Q3 Earnings Fall Y/Y, Reorder Sales Strong

by Zacks Equity Research

PetMed (PETS) sees reorder sales growth in Q3. Rising competition forced the company to offer additional discounts to customers in the quarter which had a negative impact on the gross margin.

Zacks Equity Research

Abbott (ABT) Q4 Earnings Meet Estimates, Organic Growth Solid

by Zacks Equity Research

Within Structural Heart, growth is driven by several product areas across Abbott's (ABT) broad portfolio.

Zacks Equity Research

Can Diagnostic Revenues Fuel PerkinElmer's (PKI) Q4 Earnings?

by Zacks Equity Research

PerkinElmer's (PKI) fourth-quarter 2018 results are likely to benefit from the Diagnostics Segment's solid performance.

Zacks Equity Research

Can Overall Growth Fuel Align Technology's (ALGN) Q4 Earnings?

by Zacks Equity Research

Align Technology (ALGN) is likely to gain from strength in Invisalign space as well as Scanner and Service business in fourth-quarter 2018.

Zacks Equity Research

ResMed Launches Nasal Mask Devise, Extends AirFit Portfolio

by Zacks Equity Research

ResMed's (RMD) AirFit N30i with a top-of-head connection keeps tubing out of the wearers' way, thus letting them conveniently move and sleep in any position.

Zacks Equity Research

Will Core MedSurg Segment Aid Stryker's (SYK) Q4 Earnings?

by Zacks Equity Research

Stryker's (SYK) Q4 results are likely to be aided by its core MedSurg segment.

Zacks Equity Research

Here's Why Momentum Investors Will Love DexCom (DXCM)

by Zacks Equity Research

Does DexCom (DXCM) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Equity Research

Is DexCom (DXCM) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (DXCM) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Will Instruments Fuel Intuitive Surgical (ISRG) Q4 Earnings?

by Zacks Equity Research

Intuitive Surgical's (ISRG) top line in the fourth quarter of 2018 is likely to benefit from solid grow that the Instruments and Accessories segment.

Zacks Equity Research

Varian Medical (VAR) to Report Q1 Earnings: What's in Store?

by Zacks Equity Research

Strong overseas presence and product launches are likely to aid Varian Medical's (VAR) fiscal first-quarter results.

Sreyoshi Mukherjee headshot

3 Medical Services Stocks to Buy in 2019: HQY, AMEH & OPGN

by Sreyoshi Mukherjee

Here we discuss three profitable Medical Services stocks as the industry booms.

Zacks Equity Research

AngioDynamics (ANGO) Q2 Earnings Beat on Gains From NanoKnife

by Zacks Equity Research

AngioDynamics (ANGO) sees a solid fiscal second quarter; gains from strong segmental contributions.

Zacks Equity Research

Here's Why Investors Should Bet on DexCom (DXCM) Right Now

by Zacks Equity Research

A solid guidance for 2018 and lucrative deals make DexCom (DXCM) a promising investment pick.

Zacks Equity Research

Is DexCom (DXCM) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (DXCM) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

DexCom Sees Hammer Chart Pattern: Time to Buy?

by Zacks Equity Research

DexCom has been struggling lately, but the selling pressure may be coming to an end soon.

Sapna Bagaria headshot

4 Healthcare Stocks That Popped More Than 100% in 2018

by Sapna Bagaria

Players in the Healthcare sector gained from aging population, expanding government business, technological investment, strong demand for its product and services and industry consolidation.

Zacks Equity Research

Are ABMD & DXCM Neck and Neck? Let's Take a Closer Look

by Zacks Equity Research

DexCom (DXCM) scores higher than Abiomed (ABMD) when it comes to current-year revenue projections and fundamentals.

Sweta Jaiswal headshot

4 Medical Device Stocks That More Than Doubled in 2018

by Sweta Jaiswal

Here are four medical device stocks which have performed really well in 2018 and should be on investors' radar next year as well.

Sreyoshi Mukherjee headshot

5 Stocks That Popped More Than 100% in 2018 Defying All Odds

by Sreyoshi Mukherjee

Five solid picks that defied the problems confronting the U.S. economy.

Zacks Equity Research

Has DexCom (DXCM) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Is (DXCM) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

What Falling Estimates & Price Mean for Alphatec Holdings (ATEC)

by Zacks Equity Research

Alphatec Holdings (ATEC) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.

Zacks Equity Research

DexCom (DXCM) Down 11.6% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

DexCom (DXCM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Swarup Gupta headshot

5 Stocks to Gain as Fed Chair "Blinks" on Rates

by Swarup Gupta

Investors would now best prepare for sunnier days ahead, which make it imperative to pick select growth stocks.